Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure.

[1]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[2]  W. Wodzig,et al.  Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays , 2009, Annals of clinical biochemistry.

[3]  A. Jaffe,et al.  Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. , 2009, Clinical chemistry.

[4]  Alfi Rahman,et al.  Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients , 2008, Internal medicine journal.

[5]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[6]  G. Dimeski,et al.  Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease , 2007, Annals of clinical biochemistry.

[7]  C. Herzog,et al.  Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. , 2004, Clinical chemistry.

[8]  G. London.  THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Cardiovascular Disease in Chronic Renal Failure: Pathophysiologic Aspects , 2003, Seminars in dialysis.

[9]  C. Luley,et al.  Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal Disease , 2000, Circulation.

[10]  G. Wells,et al.  Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. , 1999, Clinical biochemistry.

[11]  R. Foley,et al.  Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. , 1996, Journal of the American Society of Nephrology : JASN.

[12]  W. Wodzig,et al.  Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. , 2009, Clinical chemistry.

[13]  C. Pollock,et al.  Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.